Dr. Stabler was recently elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows! The College of Fellows is comprised of outstanding bioengineers in academia, industry and government, representing the top 2 % of medical and biological engineering professionals.

Stabler was elected for her outstanding contributions in the design of translational bioactive materials for cellular transplantation, focusing on treatment of type 1 diabetes. Stabler’s research is distinguished by its integration of engineering, biomaterials, and transplantation in a highly translational manner. Stabler’s lab explores building strong interdisciplinary collaborations to integrate biological cues and signals with rationally designed biomaterials. Through this integration, novel platforms can be developed that not only serve to provide the basic framework to the tissue, but to also dynamically interact with and instruct the surrounding host cells and environment on how to respond to the implant. In such a manner, superior implants may be developed that provide elegant and localized control of the implant microenvironment.

With this induction, Dr. Stabler can expand her interests in advocacy and education regarding public policy and government funding.